MDLZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Mondelez International Inc (MDLZ) is not a strong buy at the moment for a beginner investor with a long-term focus. The lack of significant positive catalysts, recent financial underperformance, and cautious sentiment from Congress and analysts suggest that holding off on investment is prudent. While the stock may have long-term potential, the current environment does not present an optimal entry point.
The technical indicators are neutral to slightly bearish. The MACD is negatively expanding below zero, suggesting downward momentum. RSI is neutral at 47.898, and moving averages are converging, indicating a lack of clear direction. The current price of $59.94 is below the pivot level of $60.385, with key support at $58.557 and resistance at $62.213.
Additionally, the company has been making investments to improve its long-term growth model.
Net income and EPS have dropped significantly YoY (-61.89% and -60.77%, respectively), and gross margin has also declined sharply. Congress members have been selling the stock, indicating caution. Analysts have lowered price targets, and the company’s FY26 guidance is below expectations. News sentiment suggests a shift away from consumer staples in favor of healthcare.
In Q4 2025, revenue increased by 9.29% YoY to $10.496 billion. However, net income dropped by 61.89% YoY to $665 million, and EPS fell by 60.77% YoY to $0.51. Gross margin also declined significantly to 27.83%, down 27.22% YoY. These figures indicate financial pressure despite revenue growth.
Analyst sentiment is mixed to cautious. While some firms maintain Buy or Overweight ratings, several have lowered price targets, citing near-term challenges such as pricing pressure, European disruptions, and inventory cost phasing. The average price target is in the mid-$60 range, which suggests limited upside from the current price.
